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sian on ECG and a planar thallium (TL) perfusion defect during maximal tread-
mill testing was a potent independent predictor of future coronary events
(CE) over a mean follow-up of 4.7 years in 407 asymptomatic volunteers
aged 40-96 years (mean = 60) from the Baltimore Longitudinal Study of
Aging (Circulation 1990;81 :428). To determine the longer term prognostic
significance of SI in this population. we examined the incidence and predic-
tors of CE over a mean follow-up of 9.2 years. A total of 61 CE developed (32
cases of new angina pectoris. 17 non-fatal myocardial infarctions. 12 cardiac
deaths). Events occurred in 15% of subjects with both negative ECG and TL
responses. 30% of those with either a positive ECG or TL result. and 48%
of those in whom both tests were positive (p < 0.001). By proportional haz-
ards analysis. older age (relative risk [RR] = 2.3 per 15 year incrementl. male
gender (RR = 2.2), hypertension (RR = 2.5). shorter exercise duration (RR
= 0.91 per minute). and a concordant positive ECG and TL response (RR =
2.5) were significant independent predictors of CEo Hard CEo i.e. myocardial
infarction orcardiac death, were predicted by older age (RR = 3,1), male gen-
der (RR = 2.8), current smoking (RR = 3,0). plasma cholesterol (RR = 1.01
per mg/dl). fasting plasma glucose (RR = 1,01 per mg/dll and a concordant
positive ECG and TL (RR = 3.4). Thus, at a mean follow-up of over 9 years,
exercise-induced SI remains a potent predictor of future CE in apparently
healthy volunteers. independent of conventional risk factors,
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1716-21 Myocardial Ischemia Induced by Mental Stress
Predicts a Poorer Prognosis in Patients with
Coronary Artery Disease
Wei Jiang, James A. Blumenthal, Steven E, McNulty, Michael W Hanson, R.
Edward Coleman, David J, Frid, Robert A. Waugh. James J, Morris, Christopher
M, O'Connor. Duke University Medical Center, Durham, NC
Although it is clear that mental distress elicits myocardial ischemia, the re-
lationship of mental stress-induced myocardial ischemia (MSI) to prognosis
in patients with CAD is unknown. 130 CAD patients with stable angina un-
derwent a series of mental stress and exercise tests using radionuclide ven-
triculography and standard 12-lead ECG. then were followed for one year,
Myocardial ischemia was defined as a new wall-motion abnormality, ejec-
tion fraction (EF) decrease >5%. or ST-segment depression 2:0.1 mV from
baseline, Cardiac events (CE) were defined as CABG, PTCA, unstable angina
admission requiring angiography (UA), nonfatal myocardial infarction (NMI),
and cardiac death.
Of the 130 patients. 50% had both MSI and exercise-induced ischemia
(ESI). 18% experienced MSI alone. and 18% had ESI alone. Of the 117 pa-
tients achieving one-year follow-up. 20 suffered various CE: 19 had UA, 9
had PTCA. 4 had CABG. 2 had NMI, and 1 died. Logistic regression analyses
were performed to examine the possible relationships among age, baseline
systolic blood pressure (SBP). baseline EF. MSI. ESI and CEo Results showed
that baseline SBP and MSI, but not ESI, were univariable predictors of CE
(see Table). Multivariable logistic models were then used, with age. baseline
SBP. and baseline EF as covariables. to determine if the addition of either
MSI or ESI provided prognostic information in predicting CEo MSI was inde-
pendently predictive of CE after adjustment for the covariables,
Univariable x2 p Value
Age 0.49 0.48
Baseline SBP 5.32 0,02
Baseline EF 0.001 097
MSI 4.77 0,03
ESI 0.48 0.49
In conclusion, MSI may have greater prognostic potential than ESI for a
specific population of CAD patients.
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1716-31 Prognostic Significance of Transient Ischemic
Episodes; Response to Treatment Shows ImprOVed
Prognosis. Results of the TIBBS-follow-up
Th. v. Arnim. TIBBS (Total Ischemic Burden Bisoprolol Study) investigators. Red
Cross Hospital, Munich. Germany
TIBBS is a multi-center trial in which patients with stable angina pectoris and
a positive exercise ECG were selected for randomized medical treatment
when they showed transient ischemic episodes (TIE) on 48-h-ambulatory
ECG monitoring (AECG). The follow-up study at 1 year investigates the im-
plications for the prognosis of the patients.
Of 621 patients screened on the basis of history of stable angina pectoris
and positive exercise ECG. 565 had technically sufficient 48-h-AECG. and
193 showed 0 or 1 TIE (1 mm, 1 min. 1 min. apart) 152 showed 2-6 TIE. 153
showed >6 TIE. Follow-up at one year was >90% complete, Physicians in
charge of the patients were unaware of the results of AECG,
Patients with 0-1 TIE had less cardiac events (death. AMI. CABG, PTCA,
hospitalisation for unstable A.p.) at one year (11.9%) compared to patients
with 2-6 TIE (+26.3%) or patients with >6 TIE (30.5%) (p < 0.001),
Of 268 randomized patients. those 90 patients who had shown response
to medical treatment with 100% reduction of TIE during the 8-week active
phase of TIBBS (treatment with Bisoprolol 10 mg/20 mg o,d. vs. Nifedipin
slow release 2 x 20/2 x 40 mg b,Ld.) had better prognosis: 17.8% events
compared to 30.6% events in patients with less or no reduction of TIE (p <
0,025). Patients who responded with 50% reduction of TIE showed only a
trend towards reduced risk of events: 23.3% vs 30.9% (p < 0,117).
Conclusion: AECG in patients with stable angina pectoris and positive ex-
ercise ECG selects patients with increased risk of cardiac events, Patients
who do not respond to medical treatment with reduction of TIE are at fur-
ther increased risk.
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Placebo Treatment Reduces Both the Number of
Ischemic Episodes and Duration of Ambulatory
Silent Myocardial ischemia in Patients with Stable
Angina Pectoris
Udho Thadani. University of Oklahoma HSC, Oklahoma City, OK
Ambulatory silent myocardial ischemia occurs frequently in patients with
stable exertional angina pectoris, It is widely accepted that a medication
has antiischemic effects if it reduces either the number or the duration of
silent myocardial ischemic episodes in comparison to pretreatment values.
Effect of monotherapy with placebo on silent myocardial ischemia in 33 pa-
tients who took part in a parallel group investigational drug study and were
assigned to the placebo arm of the study form the basis of this investiga-
tion. After discontinuation of all antianginal medications patients received
two weeks of single blind placebo treatment followed by four weeks of dou-
ble blind placebo treatment. Ambulatory holter monitoring was performed
for 48 hours after two weeks of single blind placebo treatment and again
after 4 weeks of double blind placebo treatment. The median value of silent
myocardial ischemia attack rate during single blind placebo treatment was
7.2 episodes per 48 hours and decreased during double blind placebo treat-
ment to a median rate of 3.1 episodes per 48 hours (P < 0.004; 95% CI.
-5.41. -1.0), Similarly the duration of silent myocardial ischemic episodes
decreased by a median of 16,1 minutes per 48 hours (P < 0,001; 95% CI.
-35.7. -6.2 minutes) during double blind placebo treatment from a median
value of 24.8 minutes per 48 hours during single blind placebo treatment.
Conclusion: placebo monotherapy had a marked influence on ambulatory
silent myocardial ischemia and reduced both the duration and number of
silent myocardial ischemic episodes in patients with stable angina pectoris.
These findings have important implications for interpretation of studies in
which the effects of active treatment on silent myocardial ischemia are com-
pared to baseline pretreatment values.
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1716-51 Treatment of Silent Ischemia in Unstable Angina: A
Randomized Comparison of Sustained-release
Verapamil Versus Metoprolol
Narendra Singh, Dmitry Mironov, Shaun Goodman, Chris 0, Morgan,
Anatoly Langer, St. Michael's Hospital, Toronto. Ontario. Canada
Silent ischemia is a frequent finding in pts with unstable angina IUA) which
portends a poor prognosis. We compared the efficacy of sustained-release
verapamil and metoprolol (M) in the treatment of silent ischemia and stud-
ied whether detection of silent ischemia was related to unfavourable out-
comes irrespective of treatments. Consecutive pts with UA were random-
ized to therapy with verapamil or metoprolol and all received nitrates, hep-
arin and aspirin by protocol. ST shift (2: 1 mm. 60-80 msec after J point and
separated by 2: 1 min from other episodes) was detected on 72 hr Holter
monitoring Ileads AVF, V2. V5)·
There were 37 pts in the verapamil (218 ± 89 mg/day) and 40 pts in the
metoprolol (88 ± 24 mg/day) group. The two groups were similar in baseline
characteristics. Recurrent angina episodes were more frequent in the ver-
apamil group 129 vs 12. p = 0.05). Overall 26 (34%) pts had 100 episodes
of ST shift, 75% ST.J,. 95% silent. Comparing the verapamil vs metoprolol
group. there was no difference in the frequency (51 vs 49 episodes, p = 0.9)
and duration (23 ± 48 min vs 18 ± 50 min, p = 0.6) of ST shift episodes. 20
in-hospital unfavourable outcomes 15-MI, 15-urgent revascularization) were
distributed equally between verapamil and metoprolol pts. However. pts with
unfavourable outcomes irrespective of treatment more often had ST shift
(50% vs 28%, P = 0.07), and with longer duration 140 ± 69 vs 13 ± 38 min,
p = 0.03), Pts with ST shift 2:60 min had a 60% probability of unfavourable
outcome compared with 33% for ST shift between 1-59 min and 20% for
pts without ST shift Ip = 0.04).
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Conclusions: Metoprolol appears to reduce symptomatic ischemia better
than verapamil, but no difference in silent ischemia and unfavourable out-
comes was seen. SI is common (34%) in UA despite heparin and aspirin
therapy. Detection of Sl is related to prognosis irrespective of treatment and
may be useful for early non-invasive risk stratification.
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1716-61 Nocturnal Blood Pressure and Myocardial Ischemia
in Patients with CAD
Joachim Muller, Ulrich T6nnesmann, Stefan Schaupp, Ingomar-Werner Franz.
KJinik Wehrawald, Todtmoos, Germany
Objective: It is welt known that B.P. rises during the day and decreases dur-
ing the night. However, patients with CAD have an impaired coronary flow
reserve and they may be endangered by myocardial ischemia due to a sub-
stantial reduction in nocturnal diastolic B.P. The purpose of the study was to
test this hypothesis. Methods: In 103 patients (82",21 ,?, mean age 60 ± 8
years) with documented CAD a 24-h ambulatory blood pressure monitoring
(SpaceLabs 90 202) and a 24-h Holter monitoring with ST-segment analysis
(Pathfinder V) was simultaneously performed. The patients were arbitrarily
divided into three groups with regard to their mean nocturnal diastolic B.P.
(10.00 p.m. - 6.00 a.m.): Group 1: <60 mmHg (58 ± 3) group 2: 61 - 70
mmHg (66 ± 3), group 3: 71 mmHg (78 ± 7). There were no significant differ-
ences between the three groups concerning age, sex distribution, coronary
status and therapy. ReSUlts: In group 1 86.2% of the patients had noctur-
nal episodes of ST-segment depression compared with 50% of group 2 and
33.3% of group 3. Group 1 patients revealed a significant higher incidence
of episodes (2.7 ± 2.4/night) compared with 1.2 ± 1.8 (p < 0.01) and 0.6 ± 1
(p < 0.001) of group 2 and 3, respectively and a significant (p < 0.001) longer
duration (1608 s versus 392 sand 143 s, respectively). Group 1 patients had a
significantly greater reduction in nocturnal diastolic B.P. with 14.3 ± 6 mmHg
compared with 11.5 ± 6 mmHg (p < 0.05) and 6.6 ± 5 mmHg (p < 0.001).
respectively.
Conclusions: In patients with CAD a low nocturnal diastolic B.P. profile «70
mmHg) goes along with a higher incidence and longer duration of silent is-
chemic episodes. A drop in perfusions pressure seems to be responsible
for that and should be taken into account when treating such patients with
antihypertensive or antiischemic drugs.
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1717-21 Echocardiography Can Predict Patients Who Develop
Severe Mitral Regurgitation Following Percutaneous
Mitral Balloon Valvuloplasty
Luis R. Padial, Nelmacy Freitas, Alex Sagie, Arthur Weyman, Mary Etta King,
Robert A. Levine, Igor F. Palacios. Massachusetts General Hospital, Eoston. MA
Although specific echocardiographic features of the mitral valve (MV) have
been shown to predict the likelihood of a successful outcome of percuta-
neous mitral valvuloplasty (PMV), they do not identify those patients who are
more likely to be a risk for significant mitral regurgitation (MR) post- PMV
Based on pathologic data from patients who developed severe post-PMV-
MR, an echocardiographic score was developed. (MR-Echo Score) which
included uneven distribution of thickness and calcification of both mitral
leaflets, degree of commissural disease and subvalvular involvement. Each
component was graded fro 0-4 and a total score (0-16) was calculated. In-
traobserver and interobserver variability for score assessment were 6% and
7% respectively.
From 566 consecutive patients who underwent PMV, 36 (6.5%) developed
severe post-PMV MR (>3+ by angiography.) The MR-Echo Score was ap-
plied to 31 of these patients (28 women; mean age 54 + 14 yr.) for whom
pre-PMV echocardiograms were available and 31 randomly selected patients
who did not develop severe post-PMV MR but were matched for age, sex.
pre-PMV MV area and degree of MR. The total MR- Echo Score was signif-
icantly greater in the severe MR group (11.7 ± 1.9 vs. 8 ± 1.2; P < 0.001).
Using a total score ~10 as a cutoff point for predicting severe post PMV
MR. a sensitivity of 90 ± 5% and a specificity of 97 ± 3% were obtained.
Stepwise logistic regression analysis identified the MR-Echo Score as the
only independent predictor for the development of severe post-PMV MR (p
< 0.0001).
Conclusions: Specific morphologic features of the mitral valve apparatus
in mitral stenosis as identified in this new MR-Echo Score predict the devel-
opment of severe post PMV MR and therefore can be useful in the selection
of patients for PMV
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1717-31 Do All Patients Undergoing Inoue Balloon Mitral
Valvotomy Need Transesophageal Echo (TEE) to
Exclude Left Atrial Thrombus?
Jai J. Patel, Robin 8. Dyer, Ravi G. Pillay, Miroslav J. Munclinger, Abdul S. Mitha.
Cardiac Unit, Wentworth Hospital/University ofNatal, Durban, South Africa
To assess merits of TEE and transthoracic echo (TIE) to exclude left atrial
body (B) or appendage (A) thrombus IT) before valvotomy, we performed
both in 151 consecutive patients (mean age 30) with tight mitral stenosis
and NYHA 111111 disability (Group I).
Tdetected on TEE Tsuspected on TEE Confirmed Surgery No T at Surgery PMV
Ii) 5(8+ -AI 5 3 1
(III 5(AI 3 5
(liiI3(AI 3
(IV) 3(AI 2
In (i), 1 pt refused surgery and 1 had PMV after 3 mths of warfarin. In liv), 2
pts had PMV and 1 no procedure. Thus 10.5% pts showed thrombus on TEE;
of these 81 % were in AF and 3 were in SR. Following on this experience, the
next 165 similar consecutive pts had TEE before PMVonly if Twas suspected
on TIE. Group II:
Alll1 pts in (ii) with TEE thrombus had uneventful PMV Thus only 16% had
TEE. Of 38 pts having PMV without TEE, minor embolic episodes occurred
in 3. All 3 had no evidence of T on post event TEE.
Conclusion: In young pts carefully performed TIE is a useful screening
procedure before PMV TEE is not mandatory and should be performed if T
suspected on TIE to exclude left atrial body thrombus as Inoue PMV IS safe
in presence of appendage thrombus.
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1717-1 I Elevated Left Ventricular End-Diastolic Pressure in
Mitral Stenosis: Reduction After Valvuloplasty
Roderick J. Sawyer, John D. Carroll, Ted Feldman, Thomas N. Levin, Gerald Dorms,
North American Inoue Investigators. The University of Chicago Hospital, Chicago, IL
Traditionally, an elevated LVEDP in mitral stenosis has implied coexistent aor-
tic valve disease, coronary artery disease, or myocardial disease and has
been a predictor of poor outcome after mitral valvuloplasty (BMV). We first
examined our local population of BMV (n = 77) and found that aortic and
coronary disease did not account for the elevated LVEDP in the majority of
patients. Secondly, we examined the Inoue BMV database. Group I (n = 844)
had pre-BMV LVEDP ~ 15 mmHg while group II (n = 200) had an LVEDP > 15
mmHg. After BMV a rise in LVEDP occurred in group I (pre: 9.9 ± 3.3 mmHg
vs post: 12.5 ± 8.6 mmHg, p < 0.05) as well as a decrease in mean LAP from
23 mmHg to 17 mmHg, p < 0.05). In contrast, group II had a fait in LVEDP
(pre: 22.7 ± 15.2 mmHg vs post: 19.8 ± 11.4 mmHg, p < 0.05) as well as a
decrease in LAP (28 mmHg to 24 mmHg, p < 0.01).
A subgroup studied at six months post-BMV revealed no change in group
I (n ~ 105) LVEDP (post: 11.5 ± 5.4 mmHg vs 11.8 ± 4.7 mmHg, p = NS)
while group II (n = 22) had a progressive fall (post: 19.9 ± 4.8 mmHg vs 13.8
± 3.8 mmHg, p < 0.01). There was no correlation between NYHA class at
six months and the pre or post BMV LVEDP.
Conclusion: An increased baseline LVEDP in mitral stenosis is not a pre-
dictor of poor outcome after mitral valvuloplasty. The fait of LVEDP supports
the claim that BMV improves LV chamber compliance perhaps by untether-
ing the restricted LV
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